Onsolis Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
Onsolis General Information
Description
The opioid analgesic brand is indicated in the management of persistent breakthrough pain, in cancer patients who have already received and are tolerant to opioid therapy for their underlying cancer pain.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
- United States
Corporate Office
- United States
Onsolis Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Onsolis FAQs
-
Where is Onsolis headquartered?
Onsolis is headquartered in .
-
What industry is Onsolis in?
Onsolis’s primary industry is Buildings and Property.
-
Is Onsolis a private or public company?
Onsolis is a Private company.
-
What is Onsolis’s current revenue?
The current revenue for Onsolis is .
-
When was Onsolis acquired?
Onsolis was acquired on 02-Aug-2023.
-
Who acquired Onsolis?
Onsolis was acquired by Adalvo.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process